86280 Hemagglutination inhibition test (HAI)

Name of the Procedure:

Hemagglutination Inhibition Test (HAI), also known as Hemagglutination Inhibition Assay.

Summary

The Hemagglutination Inhibition Test is a laboratory procedure used to measure the presence of antibodies against certain viruses in a patient's blood. By detecting these antibodies, the test helps to determine if a person has been exposed to a specific virus and has developed an immune response.

Purpose

The HAI test is primarily used to diagnose viral infections, such as influenza, by detecting the body's immune response to the virus. The test aims to identify and quantify antibodies to confirm exposure and immunity status.

Indications

• Suspected viral infections such as influenza
• Surveillance of virus spread in a population
• Post-vaccination immunity assessment
• Determining immunity status in individuals exposed to a specific virus

Preparation

• No special preparation is typically required for the patient.
• The patient may need to provide a blood sample, which may require prior scheduling.
• Patients should inform their healthcare provider about any medications they are taking.

Procedure Description

1. Blood Sample Collection: A healthcare professional draws a blood sample from the patient’s arm using a sterile needle.
2. Laboratory Processing: The blood sample is processed to separate the serum, where antibodies are found.
3. Mixing with Virus Antigen: The serum is then mixed with a known concentration of viral antigens.
4. Incubation and Observation: The mixture is incubated to allow any antibodies in the serum to interact with the antigens. Red blood cells are added after incubation.
5. Result Interpretation: If antibodies are present, they will prevent the virus from causing red blood cells to clump together (hemagglutination). The degree of inhibition is measured and interpreted.

Duration

The entire process, from blood draw to obtaining results, typically takes a few hours to a few days, depending on the laboratory's processing times.

Setting

• The blood sample is usually collected in a hospital, outpatient clinic, or doctor's office.
• The actual HAI test is performed in a specialized laboratory.

Personnel

• Phlebotomist or Nurse (for drawing blood)
• Laboratory Technicians and Technologists
• Medical Laboratory Scientists

Risks and Complications

• Common Risks: Minor bruising or discomfort at the blood draw site.
• Rare Risks: Infection at the puncture site, fainting, or excessive bleeding.
• Complications Management: Most minor complications are easily managed on-site, and patients should report any significant issues to their healthcare provider.

Benefits

• Accurate assessment of exposure to specific viruses.
• Aids in diagnosing current or past infections.
• Helps to determine immunity levels post-infection or post-vaccination.
• Results can inform public health and epidemiological decisions.

Recovery

• Post-procedure, patients can typically resume normal activities immediately.
• It is advisable to keep the puncture site clean and monitor for any signs of infection.
• Follow-up appointments may be scheduled based on the test results.

Alternatives

• ELISA (Enzyme-Linked Immunosorbent Assay): Measures antibodies or antigens in the blood, often with higher sensitivity.
• PCR (Polymerase Chain Reaction): Detects viral genetic material, useful for active infections.
• Rapid Antigen Tests: Provide quicker results but may be less accurate than HAI.
• Pros and Cons: ELISA and PCR are more sensitive but also more expensive and complex. Rapid tests are quicker but less reliable.

Patient Experience

• The blood draw may cause minimal discomfort or a slight sting.
• Patients may feel anxious waiting for results.
• Overall, the experience is generally straightforward with minimal discomfort and quick recovery.
• Pain management is usually not necessary beyond basic care of the blood draw site.